Search clinical trials for: Peptide

Total 2064 results

Robert Ferris
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Head and Neck Cancer

Head and Neck Cancer

United States
Papworth Hospital NHS Foundation Trust

Unknown

Diastolic RV EvAluation With Millar Catheter to Investigate the Effect of Glucagon-Like Peptide-1 (GLP-1) on Right Ventricular Function During Elective Coronary Angioplasty and Stenting (DREAM GLP-1)

Right Coronary Artery Percutaneous Coronary Intervention | Right Ventricular Diastolic Dysfunction

United Kingdom
Papworth Hospital NHS Foundation Trust

Completed

Cardioprotective Effects of GLP-1 and Their Mechanisms

Angina Pectoris

United Kingdom
Jules Bordet Institute

Withdrawn

Randomized Phase III of PRRT Versus Interferon (CASTOR)

Gastro-intestinal Neuroendocrine Tumors

Belgium
Oslo University Hospital

Completed

GLP-1 Effects on Insulin and Glucagon in PTDM

Post-transplant Diabetes Mellitus

Norway
National Health Research Institutes, Taiwan

Completed

A Multiple Ascending Dose Phase I Study of DBPR108 in Healthy Male Subjects

Diabetes Mellitus, Type 2

Taiwan
Grupo Rehabilitacion en Salud
Clinica Las Americas

Completed

Natriuretic Brain Pro-peptid Changes in Patients With Chronic Heart Failure Within a Cardiac Rehabilitation Program

Chronic Heart Failure

Colombia
University Hospitals Coventry and Warwickshire...
Medtronic

Unknown

Novel Vascular Biomarkers Behaviour and Clinical Value in Heart Failure and CRT (COVERT-HF)

Chronic Heart Failure

United Kingdom
Chemical Resources

Completed

Evaluation of Fenugreek Seed Extract In Type- 2 Diabetes: An Add-On Study

Diabetes
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI); Innovive Pharmaceuticals

Completed

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma

Myelodysplastic Syndromes | Leukemia | Lung Cancer | Malignant Mesothelioma | Primary Peritoneal Cavity Cancer

United States
Chinese PLA General Hospital

Unknown

Effects of Glucagon Like Peptide-1 on Haemodynamic Parameters

Heart Failure

China
Imperial College London
St Mark's Hospital Foundation; CORE

Completed

Plasma Determination of Glucagon-like Peptide 2 as a Predictor of Recovery in Adults With Acute Intestinal Failure

Short Bowel Syndrome
Indiana University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Modulation of Human Myocardial Metabolism by GLP-1 Dose Response

Healthy | Type 2 Diabetes Mellitus

United States
University of KwaZulu
University of Stellenbosch

Unknown

B-type Natriuretic Peptide Guided Therapy to Improve Clinical Outcomes for Patients Undergoing Non-cardiac Surgery (BETTER pilot)

Surgery | Risk Assessment | Cardiovascular Complications
Virginia Commonwealth University

Terminated

Nesiritide and Renal Function After the Total Artificial Heart

Congestive Heart Failure | Cardiorenal Syndrome

United States
Chen Wei Ren, MD

Unknown

Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion Injury

Acute Myocardial Infarction

China
Karolinska Institutet
Addis Ababa University; Armauer Hansen Research Institute, Ethiopia

Completed

Immune Reconstitution in Tuberculosis Disease (IRETB)

Pulmonary Tuberculosis (TB)

Ethiopia
Karolinska Institutet
Addis Ababa University; Armauer Hansen Research Institute, Ethiopia

Completed

Immune Reconstitution in HIV Disease (IREHIV) (IREHIV)

HIV Infection

Ethiopia
Diabeteszentrum Bad Lauterberg im Harz

Completed

The Reduced Insulinotropic Effect of a Continuous Infusion Relative to a Bolus Injection of GIP

Type 2 Diabetes
Monica Levy Andersen

Completed

Mother-caregivers of Children With Duchenne Muscular Dystrophy (DMDK)

Other Diseases or Conditions

Brazil
Charles University, Czech Republic
Eli Lilly and Company

Completed

Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypass (Executive)

Coronary Artery Disease | Decreased Left Ventricular Function

Czech Republic
NYU Langone Health

Completed

Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide in Patients With CNS Tumors

Tumors, Central Nervous System

United States
Rabih Said
Agenus Inc.

Withdrawn

Pilot Study to Evaluate the Effects of a Vaccine (HSPPC-96) Combined With Ipilimumab in Patients With Advanced Melanoma

Melanoma

United States
Biodel

Completed

Pharmacokinetics and Pharmacodynamics of BIOD-961 vs. Marketed Glucagons

Hypoglycemia
BCN Peptides

Completed

Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy (EUROCONDOR)

Diabetic Retinopathy

Denmark, France, Germany, Italy, Portugal, Spain, United Kingdom
GlaxoSmithKline
PPD

Withdrawn

Albiglutide Versus Placebo Added-on to Basal-Bolus Insulin Therapy in Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2
University Hospitals Bristol and Weston NHS Foundation...

Completed

Towards Simple and Non-invasive Assessment of Residual Beta-cell Function in Type 1 Diabetes

Type 1 Diabetes

United Kingdom
KGK Science Inc.
Marealis AS

Completed

Effect and Safety of Marealis RPC (Refined Peptide Concentrate) in Mild or Moderate Hypertensive Subjects

Prehypertension

Canada, United States, Czech Republic, Germany
ImmunoVaccine Technologies, Inc. (IMV Inc.)

Completed

A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate Cancer

Breast Neoplasms | Prostatic Neoplasms | Ovarian Neoplasms

United States
The Catholic University of Korea
Merck Sharp & Dohme LLC

Completed

Pharmacokinetics Study of Dipeptidyl Peptidase 4 Inhibitor to Control Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Korea, Republic of
Ian F. Pollack, M.D.
National Cancer Institute (NCI); Musella Foundation

Completed

HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas

Astrocytoma | Oligoastrocytoma | Oligodendroglioma

United States
Unidad de Investigacion en Enfermedades Cronico-Degenerativas

Withdrawn

Calcitonin in the Treatment of Fibromyalgia (CALFI)

Fibromyalgia

Mexico
Anergis
Inflamax Research Incorporated

Completed

Compare Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in EEC

Allergic Rhino-Conjunctivitis

Canada
University Health Network, Toronto

Completed

Acute Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon (Glucagon)

Diabetes

Canada
Institut Bergonié

Completed

Evolution Natriuretic Peptide Concentrations of B-type (BNP) During General Anesthesia Under Propofol and Sevoflurane Association in Patients Previously Sensitized to Anthracyclines (PEPNATB)

Breast Cancer

France
Instituto de Investigación Hospital Universitario...

Completed

Functional Bioactive Supplement Effect in Lost Weight Treatment (ALIBIRDII)

Obesity and Overweight

Spain
Siemens Healthcare Diagnostics Inc

Terminated

Serial BNP Testing for Heart Failure Management (USE-BNP)

Heart Failure

United States, Canada
University of Medicine and Dentistry of New Jersey
Scios, Inc.

Withdrawn

Double Blind Randomized Placebo Controlled Trial of Natrecor in Acute Decompensated Heart Failure With Normal EF

Pulmonary Edema | Dyspnea | Heart Failure, Congestive

United States
Vanderbilt University

Completed

Pharmacogenetics of Ace Inhibitor-Associated Angioedema

Hypertension | Diabetes Type 2

United States
Qualissima
European Union

Completed

Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment

MILD COGNITIVE IMPAIRMENT

France, Germany, Greece, Italy, Netherlands, Spain
Huashan Hospital
University of Florida; Unity Health Toronto; University of Massachusetts, Worcester

Completed

Pharmacokinetics Study of Gamma-aminobutyric Acid (GABA-PK)

Glucose Metabolism Disorders | Metabolic Diseases | Immune System Diseases | Autoimmune Diseases | Diabetes Mellitus | Endocrine System Diseases | Diabetes Mellitus, Type 1

China
Hillel Yaffe Medical Center

Unknown

Periprocedural Myocardial Infarction: the Role of Human Neutrophil Peptide-1 to 3

Coronary Thrombosis

Israel
National Cancer Institute (NCI)

Completed

Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic Melanoma

Melanoma | Skin Cancer

United States
National Cancer Institute (NCI)

Terminated

Anti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma Patients

Melanoma

United States
Hvidovre University Hospital

Unknown

The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate (ALFA-1)

Type 1 Diabetes
National Cancer Institute (NCI)

Completed

Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery

Recurrent Adult Soft Tissue Sarcoma | Stage III Adult Soft Tissue Sarcoma | Stage IV Adult Soft Tissue Sarcoma | Adult Angiosarcoma

United States
Chinese PLA General Hospital

Unknown

GLP-1 on Non-ST-Segment Elevation Myocardial Infarction

Myocardial Infarction

China
University of Wisconsin, Madison

Completed

Natrecor for Pulmonary Hypertension in Lung Transplants

Pulmonary Hypertension

United States
Axon Neuroscience SE

Completed

Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease

Alzheimer Disease

Austria
National Cancer Institute (NCI)

Completed

Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Recurrent Uterine Corpus Sarcoma | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Lung Carcinoid Tumor | Stage IV Renal Cell Cancer | Recurrent Digestive System Neuroendocrine Tumor G1 | Adult Solid Neoplasm | Stage IIIB Uterine Sarcoma | Stage IIIC Uterine Sarcoma | Stage IVA Uterine Sarcoma and other conditions

Canada

Search clinical trials for: Peptide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bangladesh

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations